Advertisement

Topics

Latest "Cobra Biomanufacturing Plc" News Stories

19:24 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "Cobra Biomanufacturing Plc" found in our extensive news archives from over 250 global news sources.

More Information about Cobra Biomanufacturing Plc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cobra Biomanufacturing Plc for you to read. Along with our medical data and news we also list Cobra Biomanufacturing Plc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cobra Biomanufacturing Plc Companies for you to search.

Showing "Cobra Biomanufacturing" News Articles 1–25 of 161

Monday 10th December 2018

Lonza to Establish Strategic Biomanufacturing Base in China

NewsGE Healthcare’s off-the-shelf biologics factory, KUBio, will provide the base for GMP manufacturing.


Lonza makes plans for major biomanufacturing plant in China

Swiss CDMO giant Lonza announced Monday that it’s partnering with GE Healthcare to build a new biomanufacturing facility in China.

MabPlex International, Ltd. Opens New Phase III and Commercial Manufacturing Facility

MabPlex International, Ltd, a global Contract Development and Manufacturing Organization (CDMO ) offering services in the development and manufacturing of biopharmaceuticals, announced the grand opening and ribbon-cutting ceremony of their new biopharmaceutical manufacturing facility in Yantai, Shandong (China). The ceremony took place on September 6, 2018. YANTAI, Shandong, China and SAN DIEGO (P...


Thursday 6th December 2018

WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market"

SHANGHAI and LONDON, Dec. 6, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company that offers end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has won the SCRIP Award in the category of "Best Company in an Emerging Market". This award recognizes the rapid growth, significant a...

Construction Begins on Large Biomanufacturing Facility in Ireland

NewsThe facility, which is the company's first site outside of China, is designed to run both traditional fed-batch or perfusion process and continuous bioprocessing.

Wednesday 5th December 2018

WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland

SHANGHAI and DUNDALK, Ireland, Dec. 5, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics...

Tuesday 4th December 2018

GE Healthcare Life Sciences Discusses Challenges of Host Cell Protein Analysis with ELISA and How to Obtain Better Coverage of Your ELISA Antibody Reagents

Sponsored by GE Healthcare Life Sciences, on December 18, join the discussion and learn about the approaches and steps to obtain reagents with good HCP coverage, from antigen selection for animal immunization, to the use of appropriate methods to determine the reagents’ coverage. YORBA LINDA, Calif. (PRWEB) December 04, 2018 Host cell protein (HCP) is a significant class of process-related impu...

Monday 3rd December 2018

KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board

Industry Experts to Provide Strategic Guidance as the Companies Advance Technologies Used in the Discovery, Analytics and Manufacturing of Difficult-to-Express Biologics KBI Biopharma, Inc. and Selexis SA announced today they have appointed four leading, internationally recognized scientists to their newly formed Joint Scientific Advisory Board (JSAB)....

Saturday 1st December 2018

Cobra Biologics Wins ‘CMO Leadership Award’ for Expertise, Quality and Service

The CMO Leadership Awards are organised by Life Science Leader magazine and recipients determined through customer feedback collected by Industry Standard Research (ISR). For the 2018 awards, which will be presented at a reception dinner at The W Hotel in New York City on March 21, more than 110 contract manufacturers were assessed by 23 performance metrics in ISR’s annual Contract Manufactu...

Friday 30th November 2018

Simultaneous consumption of cellobiose and xylose by Bacillus coagulans to circumvent glucose repression and identification of its cellobiose-assimilating operons

The use of inedible lignocellulosic biomasses for biomanufacturing provides important environmental and economic benefits for society. Efficient co-utilization of lignocellulosic biomass-derived sugars, primar...

Thursday 29th November 2018

Tosoh Bioscience LLC invests in Semba Biosciences

Tosoh Bioscience LLC announced it has completed an equity investment in Semba Biosciences with the intention of acquiring full ownership. The transaction was approved by the Board of Directors of both companies and an Equity Participation Agreement was executed on November 14, 2018. KING OF PRUSSIA, Pa. (PRWEB) November 29, 2018 Tosoh Bioscience LLC announced it has completed an equity investment...

Wednesday 28th November 2018

WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies

SHANGHAI and SEOUL, Nov. 28, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK, WuXi Bio), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and ABL Bio Corporation (ABL Bio), a privately-held South Korean biotechnology company developing antibody therapeutics for immuno-oncology and neurodegenerative...

Pall, Cobra and CGTC collaborate on continuous method for gene therapies

Innovate UK has awarded Â1.5m to three co-winners to investigate continuous manufacturing for AAV production.

Cobra Biologics to investigate continuous manufacturing of AAV for gene therapies

Cobra Biologics, an international contract development and manufacturing organization with a focus on advanced therapy medicinal products has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency.

Tuesday 27th November 2018

Department of Veterans Affairs and GE Healthcare Partner to Accelerate Use of 3D Printing in Patient Care

VA Puget Sound Health Care System and GE Healthcare are working to reduce the time it takes for radiologists to create 3D-printed models and prosthetics from hours to minutes 3D printing solutions help radiologists better visualize patient anatomy and disease for diagnosis, surgical and treatment planning - improving patient...

Monday 26th November 2018

They aren’t the type of words that usually show up in Supreme Court briefs, but on Tuesday, they will be there just the same: Cobra Sexual Energy. https://buff.ly/2TM4ewl 

They aren’t the type of words that usually show up in Supreme Court briefs, but on Tuesday, they will be there just the same: Cobra Sexual Energy. https://buff.ly/2TM4ewl 

It’s an eyebrow-raising Supreme Court case that centers on a product called “Cobra Sexual Energy” — and it highlights the FDA’s limited role overseeing dietary supplements. https://buff.ly/2DULczj 

It’s an eyebrow-raising Supreme Court case that centers on a product called “Cobra Sexual Energy” — and it highlights the FDA’s limited role overseeing dietary supplements. https://buff.ly/2DULczj 

Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies

Keele, UK, Port Washington, USA, and London, UK, 26 November 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) with a focus on advanced therapy medicinal products (ATMPs) has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation, a global leader in filtration, separat...

A SCOTUS case on ‘sexual energy’ supplements highlights FDA’s oversight of a growing industry

It’s an eyebrow-raising Supreme Court case that centers on a product called “Cobra Sexual Energy” — and it highlights the FDA’s limited role overseeing dietary supplements.

A SCOTUS case on ‘cobra sexual energy’ supplements highlights FDA’s oversight of a growing industry

It’s an eyebrow-raising Supreme Court case that centers on a product called “Cobra Sexual Energy” — and it highlights the FDA’s limited role overseeing dietary supplements.

Cobra Biologics, Pall, Cell and Gene Therapy in Continuous Mfg. Tie-up

Aims to innovate in-process analytical techniques and manufacturing approaches based on continuous chromatography platforms

Cobra, Pall, Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant

To jointly investigate continuous manufacturing of adeno-associated virus (AAV) for gene therapy applications

Saturday 24th November 2018

GE Healthcare Unveils New Applications and Smart Devices Built on “Edison” – a Next Generation Intelligence Platform

Expanding on GE Healthcare’s 200+ Imaging applications, Edison includes new technologies to improve scan consistency, help clinicians detect and prioritize acute cases and extend the lifecycle of devices Among the 100+ GE Healthcare developer services on Edison is a tool that tracks the source and usage of data in AI development, ...

Thursday 22nd November 2018

WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai

SHANGHAI, Nov. 22, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that construction of a global innovation center has commenced in the district of Fengxian in Shanghai. The new state-of-the-art biologics center will integrate biol...

Monday 19th November 2018

BioFactura Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13112018] Prices from USD $250

SummaryBioFactura Inc Biofactura is a manufacturer of biosimilars that discovers, develops and markets biodefense drugs and client selected novel drugs. The company provides contract services such as process development, stable cell lines, manufacturing, and others. Its stable cell line offers stable mammalian cell line development for high titer, scalable manufacture of monoclonal antibodies and ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks